Fingerprint
Dive into the research topics of 'A Phase I Study of Oral CC-5013 (Lenalidomide, Revlimid™), a Thalidomide Derivative, in Patients with Refractory Metastatic Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Tanyifor M. Tohnya, Sylvia S.W. Ng, William L. Dahut, John J. Wright, Philip M. Arlen, James L. Gulley, Catherine Parker, Jerome Zeldis, William D. Figg*
Research output: Contribution to journal › Article › peer-review